Publications by authors named "C G Cristea"

The mortality rate from community-acquired pneumonia (CAP) or coronavirus disease 19 (COVID-19) is high, especially in hospitalized patients. This study aimed to assess the disturbances of glucose and lipid metabolism with in-hospital complications and short-term outcomes for patients with pneumonia with different etiologies. This observational study comprised 398 patients divided as follows: 155 with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia, 129 participants with viral CAP, and 114 with bacterial pneumonia.

View Article and Find Full Text PDF

() represents one of the most frequent worldwide causes of morbidity and mortality due to an infectious agent. It is a part of the infamous ESKAPE group, which is highly connected with increased rates of healthcare-associated infections and antimicrobial resistance. can cause a large variety of diseases.

View Article and Find Full Text PDF

Illicit drugs are a global burden, not only for society, but also for the various control authorities for which its rapid on-site detection remains a challenge. In this context, the potential of a voltammetric electronic tongue (ET) for the analysis of different drugs is evaluated herein. Concretely, the discrimination and identification of cocaine, heroin, 3,4-Methylenedioxymethamphetamine (MDMA), methamphetamine and ketamine in self-prepared and real samples were attempted.

View Article and Find Full Text PDF

Cyclic peptides have emerged as an essential tool in the advancement of biomedical nanotechnologies, offering unique structural and functional advantages over linear peptides. This review article aims to highlight the roles of cyclic peptides in the development of biomedical fields, with a particular focus on their application in drug discovery and delivery. Cyclic peptides exhibit exceptional stability, bioavailability, and binding specificity, making them ideal candidates for therapeutic and diagnostic applications.

View Article and Find Full Text PDF
Article Synopsis
  • Surgery is no longer the primary treatment for prolactinomas according to current guidelines, yet it's still important for certain cases, particularly those with complications or resistant to medication.
  • The study analyzed 12 patients who underwent endoscopic transsphenoidal surgery for prolactinomas between 2013 and 2022, focusing on surgical indications, outcomes, and complications.
  • Results showed that most patients had prior treatment with dopamine agonists and experienced complications like transient diabetes insipidus, with surgery effectively recommended for those with neurological symptoms or treatment failures.
View Article and Find Full Text PDF